A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Diabetic Macular Edema
Interventions
DRUG

Iluvien 0.19 MG Drug Implant

0.19 mg Fluocinolone Acetonide Intravitreal Implant

DRUG

Aflibercept

2 mg/0.05 mL Aflibercept Anti-VEGF intravitreal injection

Trial Locations (40)

16507

Investigative Site, Erie

20186

Investigative Site, Warrenton

21237

Investigative Site, Baltimore

22106

Investigative Site, Cleveland

24018

Investigative Site, Roanoke

29169

Investigative Site, Columbia

30060

Investigative Site, Marietta

30328

Investigative Site, Sandy Springs

32806

Investigative Site, Orlando

33418

Investigative Site, Palm Beach Gardens

33609

Investigative Site, Tampa

33761

Investigative Site, Clearwater

44122

Investigative Site, Beachwood

44505

Investigative Site, Youngstown

45242

Investigative Site, Cincinnati

48201

Investigative Site, Detroit

48439

Investigative Site, Grand Blanc

60126

Investigative Site, Elmhurst

60304

Investigative Site, Oak Park

60439

Investigative Site, Lemont

62704

Investigative Site, Springfield

64055

Investigative Site, Independence

66204

Investigative Site, Shawnee Mission

66211

Investigative Site, Leawood

71291

Investigative Site, West Monroe

72815

Investigative Site, San Antonio

74114

Investigative Site, Tulsa

75231

Investigative Site, Dallas

77030

Investigative Site, Houston

77384

Investigative Site, The Woodlands

78240

Investigative Site, San Antonio

78503

Investigative Site, McAllen

80909

Investigative Site, Colorado Springs

85020

Investigative Site, Phoenix

85704

Investigative Site, Tucson

90211

Investigative Site, Beverly Hills

91203

Investigative Site, Glendale

92653

Investigative Site, Laguna Hills

92705

Investigative Site, Santa Ana

07003

Investigative Site, Bloomfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alimera Sciences

INDUSTRY